1. Home
  2. ALLT vs EBS Comparison

ALLT vs EBS Comparison

Compare ALLT & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

N/A

Current Price

$7.97

Market Cap

381.1M

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$6.42

Market Cap

312.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLT
EBS
Founded
1996
1998
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
381.1M
312.8M
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
ALLT
EBS
Price
$7.97
$6.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$12.40
$12.00
AVG Volume (30 Days)
242.4K
1.1M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
N/A
Revenue
N/A
$742,900,000.00
Revenue This Year
$15.84
$1.29
Revenue Next Year
$12.09
N/A
P/E Ratio
$469.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.12
$4.36
52 Week High
$11.92
$14.06

Technical Indicators

Market Signals
Indicator
ALLT
EBS
Relative Strength Index (RSI) 56.50 56.06
Support Level $7.38 $4.36
Resistance Level $8.12 $6.60
Average True Range (ATR) 0.25 0.34
MACD 0.06 0.12
Stochastic Oscillator 59.82 78.18

Price Performance

Historical Comparison
ALLT
EBS

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: